Found 11 matching trials
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
PHASE1This is an exploratory study in a small, well controlled group of healthy s...
Location
Jasper Clinical Research & Development, Inc.
Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury
PHASE1The main purpose of this trial is to demonstrate the safety, tolerability a...
Location
Anaheim Clinical Trials, LLC
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
PHASE2This is a Phase 2, multicenter, open-label extension (OLE) of study CXA-10-...
Location
University of Alabama
Study of CXA-10 in Healthy Volunteers
PHASE1This will be the first-in-human (FIH) study with CXA-10. The main purpose o...
Location
Jasper Clinical Research & Development, Inc.
Oral CXA-10 Study in Healthy Volunteers
PHASE1This will be the first-in-human (FIH) study with the oral formulation of CX...
Location
Jasper Clinical Research & Development, Inc.
Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
PHASE2The main purpose of this Phase 2 double blind, placebo controlled crossover...
Location
University of Colorado Anschutz Medical Campus
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
PHASE2This is a multicenter, open label, randomized study investigating two dose ...
Location
Alabama Neurology Consultants
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
PHASE2This is a multicenter double-blind, placebo-controlled study to evaluate th...
Location
University of Alabama
Anti-Inflammatory Lipid Mediators in Asthma
PHASE2The purpose of this study is to demonstrate the efficacy and safety of 10-n...
Location
The University of Pittsburgh Asthma Institute at UPMC
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
PHASE1The main purpose of this trial is to demonstrate the safety, tolerability a...
Location
Jasper Clinical Research & Development, Inc.